Thus, changes in FKBP51 expression and function are associated with the occurrence of a wide variety of disorders, including metabolic syndrome (65), Alzheimer's disease (66), the development of different types of cancer, cardiovascular disease, and immune disturbances, in addition to stress-induced psychiatric disorders (67, 68). This evidence concerns the gene FKBP5 and cancer.